DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Triazolam (Triazolam) - Stevens-Johnson Syndrome - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Stevens-Johnson Syndrome (4)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Triazolam where reactions include stevens-johnson syndrome. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Triazolam side effects in female

Reported by a physician from Japan on 2012-06-19

Patient: female

Reactions: LIP Swelling, Eyelid Oedema, Eye Discharge, Scab, Pyrexia, Erythema, LIP Erosion, C-Reactive Protein Increased, Conjunctival Hyperaemia, Dizziness, Oral Mucosa Erosion, Erythema Multiforme, Blister, Stevens-Johnson Syndrome, White Blood Cell Count Increased, Papule, Rash

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lamictal
    Dosage: 50mg per day
    Administration route: Oral
    Start date: 2012-04-27
    End date: 2012-05-05

Triazolam
    Dosage: .125mg per day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-03-28
    End date: 2012-05-05

Lamictal
    Dosage: 25mg per day
    Administration route: Oral
    Indication: Bipolar Disorder
    Start date: 2012-04-21
    End date: 2012-04-26



Possible Triazolam side effects in female

Reported by a physician from Japan on 2012-06-08

Patient: female

Reactions: LIP Swelling, C-Reactive Protein Increased, Dizziness, Rash, White Blood Cell Count Increased, Stevens-Johnson Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Triazolam
    Dosage: .125mg per day
    Administration route: Oral
    Start date: 2012-03-28
    End date: 2012-05-05

Lamictal
    Dosage: 25mg per day
    Administration route: Oral
    Indication: Bipolar Disorder
    Start date: 2012-04-21
    End date: 2012-04-26

Lamictal
    Dosage: 50mg per day
    Administration route: Oral
    Start date: 2012-04-27
    End date: 2012-05-05



Possible Triazolam side effects in 72 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2011-11-30

Patient: 72 year old male

Reactions: Dyspnoea, Rhabdomyolysis, Pyrexia, Rash, Erythema, Mucosal Erosion, Malaise, Disease Recurrence, Interstitial Lung Disease, Oral Mucosa Erosion, Oxygen Saturation Decreased, Stevens-Johnson Syndrome, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Triazolam
    Dosage: per oral
    Administration route: Oral
    End date: 2011-08-04

Doral
    Dosage: per oral
    Administration route: Oral
    End date: 2011-08-04

Feburic (Febuxostat)
    Dosage: 10 mg (10 mg,1 in 1 d) per oral ; 10 mg (10 mg,1 in 1 d) per oral
    Administration route: Oral
    Indication: Hyperuricaemia
    Start date: 2011-08-02
    End date: 2011-08-03

Feburic (Febuxostat)
    Dosage: 10 mg (10 mg,1 in 1 d) per oral ; 10 mg (10 mg,1 in 1 d) per oral
    Administration route: Oral
    Indication: Gout
    Start date: 2011-08-02
    End date: 2011-08-03

Feburic (Febuxostat)
    Dosage: 10 mg (10 mg,1 in 1 d) per oral ; 10 mg (10 mg,1 in 1 d) per oral
    Administration route: Oral
    Indication: Hyperuricaemia
    Start date: 2011-07-01
    End date: 2011-07-04

Feburic (Febuxostat)
    Dosage: 10 mg (10 mg,1 in 1 d) per oral ; 10 mg (10 mg,1 in 1 d) per oral
    Administration route: Oral
    Indication: Gout
    Start date: 2011-07-01
    End date: 2011-07-04

Allopurinol
    Dosage: (100 mg) per oral
    Administration route: Oral
    Start date: 2011-07-01
    End date: 2011-08-04

Zolpidem Tartrate

Other drugs received by patient: Folic Acid; Betamethasone; Metolate (Methotrxate); Arcrane (Sodium Alginate); Etisedan (Etizolam)



Possible Triazolam side effects in 72 year old male

Reported by a individual with unspecified qualification from Japan on 2011-10-28

Patient: 72 year old male

Reactions: Rhabdomyolysis, Interstitial Lung Disease, Decreased Appetite, Stevens-Johnson Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doral
    End date: 2011-08-04

Feburic (Febuxostat)
    Dosage: 10 mg (10 mg,1 in 1 d) per oral ; 10 mg (10 mg,1 in 1 d) per oral
    Administration route: Oral
    Indication: Gout
    Start date: 2011-07-01
    End date: 2011-07-04

Feburic (Febuxostat)
    Dosage: 10 mg (10 mg,1 in 1 d) per oral ; 10 mg (10 mg,1 in 1 d) per oral
    Administration route: Oral
    Indication: Gout
    Start date: 2011-08-02
    End date: 2011-08-04

Triazolam
    Dosage: per oral
    Administration route: Oral
    End date: 2011-08-04

Zolpidem Tartrate

Allopurinol
    Dosage: 100 mg (100 mg) oral
    Administration route: Oral
    Start date: 2011-07-01
    End date: 2011-08-04

Other drugs received by patient: Betamethasone; Metolate (Methotrexate); Arcrane (Sodium Alginate); Etisedan (Etizolam); Folic Acid

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017